PMC6717510

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54

Aortic stenosis was significantly associated with an increased risk of recurrent myocardial infarction in MI patients treated with DAPT, with consistent results across Sweden and Denmark.

Effect: decline; HR 1.78; CI: 95% CI 1.25-2.54